Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

Brasil Notícia Notícia

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 71%

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue LongCOVID COVID Brain BrainFog ChronicFatigue Fatigue medrxivpreprint IcahnMountSinai

Study: Transcutaneous Vagus Nerve Stimulation in the Treatment of Long Covid-Chronic Fatigue Syndrome. Image Credit: fizkes / Shutterstock

About the study The current study was an open-label pilot study wherein the researchers enrolled 16 subjects who had survived coronavirus disease 2019 but experienced its symptoms for at least six months following recovery. They fulfilled the 1994 case definition for CFS and also signed Institutional Review Board -approved informed consent to participate in this study via RedCap.

Related Stories Likewise, the priori criterion for the secondary outcome and successful outcome was an improvement by at least 10 points on the POMS short version and at least a third of patients fulfilling the criteria for the primary outcome, respectively. Conclusions To summarize, 8/14 patients fulfilled a priori criteria for improvement. Additionally, five patients, including four fulfilling criteria for successful improvement and one who did not show improvement, also showed reductions of at least 10 points on the POMS.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NewsMedical /  🏆 19. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke RegistryBackground and objectives: COVID-19 related inflammation, endothelial dysfunction and coagulopathy may increase the bleeding risk and lower efficacy of revascularization treatments in patients with acute ischemic stroke. We aimed to evaluate the safety and outcomes of revascularization treatments in patients with acute ischemic stroke and COVID-19. Methods: Retrospective multicenter cohort study of consecutive patients with acute ischemic stroke receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021, tested for SARS-CoV-2 infection. With a doubly-robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT). Results: Of a total of 15128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19. 5848 (38.7%) patients received IVT-only, and 9280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted odds ratio [OR] 1.53; 95% CI 1.16–2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20–2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23–1.99), 24-hour (OR 2.47; 95% CI 1.58–3.86) and 3-month mortality (OR 1.88; 95% CI 1.52–2.33). COVID-19 patients also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26–1.60). Discussion: Patients with acute ischemic stroke and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 treated patients. Current available data does not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in COVID-19 patients, or to establish different treatment recommendations in this subgro
Consulte Mais informação »

Does fenofibrate improve clinical outcomes in patients with COVID-19?Does fenofibrate improve clinical outcomes in patients with COVID-19?Does fenofibrate improve clinical outcomes in patients with COVID-19? NatMetabolism Penn udes_oficial COVID19 coronavirus covid metabolism
Consulte Mais informação »

Financial markets bet on an end to China’s “zero-covid” policyFinancial markets bet on an end to China’s “zero-covid” policyThere are some signs change may be on the way
Consulte Mais informação »

I'm A Celebrity: Matt Hancock told breaking Covid rules was 'slap in face'I'm A Celebrity: Matt Hancock told breaking Covid rules was 'slap in face'An I'm a Celebrity campmate challenges the MP about his behaviour which led to his resignation.
Consulte Mais informação »

UK companies took Covid support funds needlessly, report finds\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Consulte Mais informação »



Render Time: 2025-02-23 05:21:59